Patent · US Active

Compounds as cannabinoid receptor ligands

US8895592B2 · kind B2 · utility

2Cited by

45References

12Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Jennifer M. Frost · Grayslake, US
Steven P. Latshaw · Round Lake, US
Michael J. Dart · Highland Park, US
William A. Carroll · Evanston, US
Arturo Perez-Medrano · Grayslake, US
Teodozyj Kolasa · Lake Villa, US
Meena Patel · Libertyville, US
Derek W. Nelson · Troy, US
Tongmei Li · Lake Bluff, US
Sridhar Peddi · Grayslake, US
Xueqing Wang · Evanston, US
Bo Liu · Beijing, CN

Key dates

Filing date	Dec 16, 2009
Grant date	Nov 25, 2014
Priority date	—
Expiry date	Dec 29, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are cannabinoid receptor ligands of formula (I)wherein L1, A1, R1g, z, R2, R3, and R4 are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.